Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 13 Dec 2024 for Lumos Pharma, INC..
Filing timeline
BuySaleAaron Schuchart
Insider track record
Disclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Aaron Schuchart: trading record in brief
This profile gathers the share dealings of Aaron Schuchart across 2 companies, led by Lumos Pharma, Inc. and Spyre Therapeutics, Inc. Between 17 August 2018 and 12 December 2024, the trades on record add up to 12 filings.
On the open market, the record shows 2 purchases worth €13k and 2 sales worth €49k. Netting one side against the other leaves €36k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 1 option exercise.
On 13 December 2024 came the latest disclosure, a transaction in Lumos Pharma, Inc. The last purchase on record was published on 13 August 2021, which is 1,897 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Aaron Schuchart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,179 sharesCommon StockSEC:0001126234-24-000114:0
1,000 shares@ US$2.8415.3% of flowCommon StockSEC:0001126234-24-000034:0
202 shares@ US$3.013.3% of flowCommon StockSEC:0001126234-24-000013:0
1,000 shares@ US$3.5218.8% of flowCommon StockSEC:0001126234-23-000018:0
1,000 shares@ US$10.0251.7% of flowCommon StockSEC:0001126234-22-000012:0
300 shares@ US$7.3510.9% of flowCommon StockSEC:0001126234-21-000113:0
Canonical exit: 9 Nov 2021 (T+90)
6 of 6 declarations
